Viz.ai
PrivateLast Round
Debt
Mar 22, 2023
Est. Valuation
$1.2B
Total Funding Raised
$289.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Viz.ai is a healthtech company that offers an AI-powered intelligent care coordination platform designed to accelerate disease detection and improve clinical workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Workflow Automation, Medical Imaging, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viz.ai Comparables
Compare Viz.ai with similar companies based on industry and business-model similarity.
Viz.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 22, 2023 | ||||
| Series D | Apr 7, 2022 | ||||
| Series C | Mar 17, 2021 | ||||
| Series B | Oct 23, 2019 | ||||
| Series A | Jul 18, 2018 | ||||
Seed | May 24, 2017 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER |
Key People
Founding team and executive leadership
Viz.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Greenoaks Capital Partners | Series C, Series B |
| Threshold Ventures | Series D, Series C, Series B |
| GV | Series D, Series A, Series B |
| Innovation Endeavors | Series C, Seed |
| Tribe Capital | Series D |
| CIBC Innovation Banking | Debt |
| Scale Venture Partners | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Organization grew to approximately 150 employees.
- Apr 23, 2026
Collaborating with Johnson & Johnson to expand Subdural Hemorrhage software access.
Recent news
Latest coverage and updates
- recognized_asJul 28, 2026
Viz.ai, Inc. recognized as #1 in AI-powered clinical decision support on Jul 28th '26.
- recognized_asJul 9, 2026
Viz.ai, Inc. recognized as #1 Healthcare AI Platform on Jul 9th '26.
- partners_withJul 9, 2026
Viz.ai, Inc. partnered with Cortechs.ai, Inc. on Jul 9th '26.
Viz.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Viz.ai's valuation, stock price, and market status.
Is Viz.ai a public or private company?
Viz.ai is a private company.
What is the current stock price of Viz.ai?
Viz.ai is a private company with no public stock price. Caplight tracks Viz.ai's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Viz.ai worth (valuation)?
Viz.ai's valuation is estimated at $1.2B based on funding round data.
Can I buy Viz.ai stock?
Viz.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Viz.ai's last funding round?
Viz.ai's most recent funding round was Debt on April 7, 2022.
Who are the main investors in Viz.ai?
Key investors in Viz.ai include Innovation Endeavors, CIBC Innovation Banking, Scale Venture Partners, Tiger Global Management, Kleiner Perkins.
Will Viz.ai IPO soon?
No public IPO plans have been announced for Viz.ai.
How can I track Viz.ai secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Viz.ai's secondary market activity and sign up for updates.